{"id":51228,"date":"2026-06-23T08:26:37","date_gmt":"2026-06-23T06:26:37","guid":{"rendered":"https:\/\/semaxpolska.com\/?p=51228"},"modified":"2026-06-22T09:23:57","modified_gmt":"2026-06-22T07:23:57","slug":"selank-pret-afobazole-divas-krievu-zales-pret-trauksmi-ar-atskirigu-iedarbibu","status":"publish","type":"post","link":"https:\/\/bioevidencehub.com\/lv\/selank-vs-afobazole-dwa-rosyjskie-srodki-przeciwlekowe-o-odmiennym-dzialaniu\/","title":{"rendered":"Selank vs Afobazol \u2013 Divi Krievu Pretsl\u012bksto\u0161ie L\u012bdzek\u013ci Ar At\u0161\u0137ir\u012bgu Darb\u012bbu"},"content":{"rendered":"

Selank un Afobazole ir divas Krievij\u0101 izstr\u0101d\u0101tas z\u0101les, kas paredz\u0113tas trauksmes mazin\u0101\u0161anai un stresa notur\u012bbas uzlabo\u0161anai. Lai gan abiem ir pret trauksmi iedarb\u012bba, neizraisot iev\u0113rojamu miegain\u012bbu, tie at\u0161\u0137iras p\u0113c sast\u0101va, lieto\u0161anas veida, darb\u012bbas meh\u0101nisma un efektu iest\u0101\u0161an\u0101s \u0101truma.<\/p>\n

Kas ir Selank un Afobazole?<\/h3>\n

Selank ir sint\u0113tisks heptapept\u012bds, kas sast\u0101v no septi\u0146iem aminosk\u0101b\u0113m. Tas tika izstr\u0101d\u0101ts k\u0101 dabisk\u0101 pept\u012bda tufts\u012bna analogs, kas piedal\u0101s im\u016bnsist\u0113mas un nervu sist\u0113mas savstarp\u0113j\u0101 sazi\u0146\u0101. Selank tiek ievad\u012bts degun\u0101, un p\u0113t\u012bjumi liecina, ka tas \u013coti \u0101tri var sasniegt centr\u0101lo nervu sist\u0113mu. Tas tika izstr\u0101d\u0101ts Krievij\u0101 un Ukrain\u0101 90. gados un tur ir apstiprin\u0101ts trauksmes trauc\u0113jumu un ar stresu saist\u012btu st\u0101vok\u013cu \u0101rst\u0113\u0161anai.<\/p>\n

Afobazols (fabomotizols) savuk\u0101rt ir sint\u0113tisks \u0137\u012bmisks savienojums, kas pieejams table\u0161u veid\u0101. Tas tika izstr\u0101d\u0101ts ar\u012b Krievij\u0101 90. gadu beig\u0101s. Tas galvenok\u0101rt darbojas, aktiviz\u0113jot sigma-1 receptorus, kas piedal\u0101s \u0161\u016bnu atbildes reakciju uz stresu regul\u0113\u0161an\u0101. T\u0101pat k\u0101 Selank, tas tika izstr\u0101d\u0101ts, lai nerad\u012btu b\u016btisku sed\u0101ciju.<\/p>\n

K\u0101 tie iek\u013c\u016bst organism\u0101?<\/h2>\n
\n
\n
\n\n\n\n\n\n\n\n\n
Ciets<\/th>\nSelank<\/th>\nAfobazols<\/th>\n<\/tr>\n<\/thead>\n
Lieto\u0161anas veids<\/strong><\/td>\nDeguna aerosols \u2013 da\u017eas dozas katrai n\u0101sij<\/td>\nTablete, ko lieto iek\u0161\u0137\u012bgi, parasti 3 reizes dien\u0101<\/td>\n<\/tr>\n
Cik \u0101tri tas non\u0101k smadzen\u0113s<\/strong><\/td>\n\u013boti \u0101tri \u2013 caur deguna dobumu tie\u0161i uz smadzen\u0113m, apejot gremo\u0161anas procesu<\/td>\nTas uzs\u016bcas caur gremo\u0161anas traktu; maksim\u0101lo koncentr\u0101ciju asin\u012bs sasniedz apm\u0113ram p\u0113c 1 stundas<\/td>\n<\/tr>\n
Cik ilgi tas darbojas<\/strong><\/td>\nGalvenais[pept\u012bds]ir sadal\u012bts apm\u0113ram 2 min\u016b\u0161u laik\u0101, bet akt\u012bvie fragmenti var darboties 3\u20134 stundas.<\/td>\nGalven\u0101 viela tiek elimin\u0113ta sal\u012bdzino\u0161i \u0101tri (apm\u0113ram 50 min\u016btes), savuk\u0101rt t\u0101s metabol\u012bts paliek akt\u012bvs pat l\u012bdz 6 stund\u0101m.<\/td>\n<\/tr>\n
K\u0101 organisms to izvada<\/strong><\/td>\nSadalo\u0161ams nekait\u012bgos prote\u012bnu fragmentos un izvad\u0101ms caur nier\u0113m 24 stundu laik\u0101<\/td>\nAptuveni 85% tiek izdal\u012bts caur nier\u0113m, bet 15% \u2014 caur gremo\u0161anas traktu; piln\u012bb\u0101 izdal\u0101s vienas dienas laik\u0101<\/td>\n<\/tr>\n
Cik vielu k\u013c\u016bst biolo\u0123iski pieejamas<\/strong><\/td>\nAugsta pieejam\u012bba smadzen\u0113s, pateicoties intranaz\u0101lai ievad\u012b\u0161anai un aknu metabolismu apietij.<\/td>\nAptuveni 43\u2013551 TP30T no uz\u0146emt\u0101s devas non\u0101k asinsrit\u0113 p\u0113c tam, kad t\u0101 ir izg\u0101jusi cauri akn\u0101m<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<\/div>\n<\/div>\n
\n

K\u0101 mazin\u0101t trauksmi?<\/h2>\n

Abi prepar\u0101ti mazina trauksmes simptomus, nedarbojoties k\u0101 tipiski nomierino\u0161i l\u012bdzek\u013ci vai miegaz\u0101les. Neviens no tiem nav paredz\u0113ts miegain\u012bbas izrais\u012b\u0161anai.<\/p>\n

\n
\n
\n\n\n\n\n\n\n\n\n\n
Ciets<\/th>\nSelank<\/th>\nAfobazols<\/th>\n<\/tr>\n<\/thead>\n
Galven\u0101 pret trauksmi darb\u012bba<\/strong><\/td>\nAtbalsta GABA \u2013 galven\u0101 inhib\u0113jo\u0161\u0101 neiromediatora \u2013 darb\u012bbu, nep\u0101rm\u0113r\u012bgi nesl\u0101p\u0113jot smadze\u0146u aktivit\u0101ti<\/td>\nAktiviz\u0113 sigma-1 receptorus, kas pal\u012bdz \u0161\u016bn\u0101m tikt gal\u0101 ar stresa sign\u0101liem; ietekm\u0113 ar\u012b melaton\u012bna receptorus<\/td>\n<\/tr>\n
Ietekme uz smadze\u0146u vesel\u012bbu<\/strong><\/td>\nPalielina BDNF un NGF l\u012bmeni, atbalstot neironu sazi\u0146u, atmi\u0146u un koncentr\u0113\u0161anos<\/td>\nVar palielin\u0101t BDNF, aktiviz\u0113jot sigma-1 receptorus, atbalstot nervu \u0161\u016bnu atjauno\u0161anos<\/td>\n<\/tr>\n
Ietekme uz garast\u0101vokli<\/strong><\/td>\nMa izsmalcin\u0101tu ietekmi uz seroton\u012bna un dopam\u012bna ce\u013ciem, ar vieglu pa\u0161saj\u016btu uzlabojo\u0161u efektu.<\/td>\nIeguvumi galvenok\u0101rt saist\u012bti ar stresa un trauksmes regul\u0113\u0161anu, nevis tie\u0161u garast\u0101vok\u013ca uzlabo\u0161anu<\/td>\n<\/tr>\n
Ietekme uz im\u016bnsist\u0113mu<\/strong><\/td>\nTam piem\u012bt im\u016bnmodul\u0113jo\u0161as \u012bpa\u0161\u012bbas, un tas var ietekm\u0113t iekaisuma procesu regul\u0101ciju<\/td>\nPrets\u0101rmuma iedarb\u012bba \u0161\u0137iet iev\u0113rojami v\u0101j\u0101ka<\/td>\n<\/tr>\n
Sed\u0101cijas risks<\/strong><\/td>\nNetika nov\u0113rota b\u016btiska miegain\u012bba<\/td>\nNetika nov\u0113rota b\u016btiska miegain\u012bba<\/td>\n<\/tr>\n
Atkar\u012bbas risks<\/strong><\/td>\nNav pier\u0101d\u012bjumu par toleranci, atkar\u012bbu vai abstinences simptomiem<\/td>\nP\u0113t\u012bjumos, kas ilga l\u012bdz 12 ned\u0113\u013c\u0101m, netika zi\u0146ots par atkar\u012bbu vai abstinences simptomiem<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<\/div>\n<\/div>\n
\n

K\u0101 tie efekt\u012bvi darbojas?<\/h2>\n
\n
\n
\n\n\n\n\n\n\n\n\n\n\n\n
Ciets<\/th>\nSelank<\/th>\nAfobazols<\/th>\n<\/tr>\n<\/thead>\n
S\u0101kums<\/strong><\/td>\n\u0100tri \u2013 pirmie rezult\u0101ti var par\u0101d\u012bties 20\u201360 min\u016b\u0161u laik\u0101<\/td>\nPak\u0101peniski \u2013 pilna pret trauksmi iedarb\u012bba parasti att\u012bst\u0101s p\u0113c 2\u20134 ned\u0113\u013cu regul\u0101ras lieto\u0161anas<\/td>\n<\/tr>\n
Tipisk\u0101 devu lieto\u0161ana p\u0113t\u012bjumos<\/strong><\/td>\n400\u2013600 mikrogramu intranaz\u0101li, 1\u20133 reizes dien\u0101<\/td>\n10 mg tr\u012bs reizes dien\u0101 (kop\u0101 30 mg dien\u0101)<\/td>\n<\/tr>\n
Galven\u0101s p\u0113tniec\u012bbas jomas<\/strong><\/td>\nVisp\u0101r\u0113ji trauksmes trauc\u0113jumi, \u012bslaic\u012bgs stress, ar stresu saist\u012btas atmi\u0146as un koncentr\u0113\u0161an\u0101s probl\u0113mas<\/td>\nVisp\u0101r\u0113ji trauksmes, adapt\u0101cijas trauc\u0113jumi un atbalsts nikot\u012bna atkar\u012bbas p\u0101rtrauk\u0161anai<\/td>\n<\/tr>\n
Kl\u012bniskie p\u0113t\u012bjumi<\/strong><\/td>\nAptuveni 15 kl\u012bnisko p\u0113t\u012bjumu Krievij\u0101 un Ukrain\u0101; rezult\u0101ti lab\u0101ki nek\u0101 placebo un sal\u012bdzin\u0101mi ar vec\u0101kiem anksiol\u012btiskiem medikamentiem<\/td>\nVair\u0101k nek\u0101 20 kl\u012bniskie p\u0113t\u012bjumi Krievij\u0101, da\u017eos piedal\u012bj\u0101s l\u012bdz pat 500 pacientiem; tika par\u0101d\u012bts ieguvums sal\u012bdzin\u0101jum\u0101 ar placebo<\/td>\n<\/tr>\n
Ietekme uz atmi\u0146u un koncentr\u0113\u0161anos<\/strong><\/td>\nLabi dokument\u0113ti ieguvumi darba atmi\u0146ai, uzman\u012bbai un gar\u012bgajai sp\u0113jai, \u012bpa\u0161i stresa situ\u0101cij\u0101s<\/td>\nIeguvumi kognit\u012bvaj\u0101s jom\u0101s \u0161\u0137iet sekund\u0101ri un nav p\u0113t\u012bjumu galvenais m\u0113r\u0137is.<\/td>\n<\/tr>\n
Blakuspar\u0101d\u012bbas<\/strong><\/td>\nMaiga un reta: neliels deguna kairin\u0101jums, p\u0101rejo\u0161s nogurums, gad\u012bjuma galvass\u0101pes<\/td>\nVieglas un reti: slikta d\u016b\u0161a, nelielas ku\u0146\u0123a darb\u012bbas trauc\u0113jumi un reti aler\u0123iskas reakcijas<\/td>\n<\/tr>\n
Mijiedarb\u012bba ar cit\u0101m viel\u0101m<\/strong><\/td>\nNav zin\u0101mas b\u016btiskas mijiedarb\u012bbas ar aknu enz\u012bmiem<\/td>\nMetaboliz\u0113ts ar CYP3A4 enz\u012bmu, t\u0101d\u0113\u013c var mijiedarboties ar da\u017e\u0101m z\u0101l\u0113m<\/td>\n<\/tr>\n
Visliel\u0101kais ierobe\u017eojums<\/strong><\/td>\nLiel\u0101k\u0101 da\u013ca p\u0113t\u012bjumu tika veikti tikai Krievij\u0101 un Ukrain\u0101; ierobe\u017eoti ilgtermi\u0146a dati<\/td>\nL\u012bdz\u012bgi \u0123eogr\u0101fiskie ierobe\u017eojumi un lielo kl\u012bnisko p\u0113t\u012bjumu tr\u016bkums ASV, Lielbrit\u0101nij\u0101 un ES<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<\/div>\n<\/div>\n

K\u0101 darbojas trauksme?<\/h2>\n

Abi prepar\u0101ti mazina trauksmes simptomus, ta\u010du tie darbojas, izmantojot at\u0161\u0137ir\u012bgus biolo\u0123iskos meh\u0101nismus.<\/p>\n

Selank<\/h3>\n

P\u0113t\u012bjumi r\u0101da, ka Selank:<\/p>\n

    \n
  • modul\u0113 GABAer\u0123isko signaliz\u0101ciju,<\/li>\n
  • ietekmi uz neirotrofiskajiem faktoriem, piem\u0113ram, BDNF un NGF,<\/li>\n
  • var uzk\u0101pt uz seroton\u012bna un dopam\u012bna sist\u0113m\u0101m,<\/li>\n
  • nor\u0101da uz neiroregul\u0113jo\u0161\u0101m un im\u016bnomodul\u0113jo\u0161\u0101m \u012bpa\u0161\u012bb\u0101m.<\/li>\n<\/ul>\n

    Afobazols<\/h3>\n

    P\u0113t\u012bjumi liecina, ka Afobazols:<\/p>\n

      \n
    • aktiviz\u0113 sigma-1 receptorus,<\/li>\n
    • atbalsta \u0161\u016bnu adapt\u0101ciju pie stresa,<\/li>\n
    • var uz to izrais\u012bt uz melaton\u012bna receptoriem,<\/li>\n
    • galvenok\u0101rt koncentr\u0113jas uz hroniska stresa un trauksmes regul\u0113\u0161anu.<\/li>\n<\/ul>\n

      Neviens no prepar\u0101tiem netika izstr\u0101d\u0101ts k\u0101 klasisks sedat\u012bvs l\u012bdzeklis, un abiem \u0161\u0137iet zems sed\u0101cijas un atkar\u012bbas risks.<\/p>\n

      Kur\u0161 darbojas \u0101tr\u0101k?<\/h2>\n

      Viena no liel\u0101kaj\u0101m at\u0161\u0137ir\u012bb\u0101m starp \u0161\u012bm viel\u0101m ir efektu iest\u0101\u0161an\u0101s laiks.<\/p>\n

      Selank<\/strong> tiek p\u0113t\u012bts galvenok\u0101rt saist\u012bb\u0101 ar \u0101tr\u0101ku spriedzes un stresa mazin\u0101\u0161anu un kognit\u012bvo funkciju atbalst\u012b\u0161anu.<\/p>\n

      Afobazols<\/strong> parasti prasa regul\u0101ru lieto\u0161anu vair\u0101kas ned\u0113\u013cas, un to bie\u017e\u0101k apskata saist\u012bb\u0101 ar hronisku, notur\u012bgu trauksmi.<\/p>\n

      Ietekme uz kognit\u012bvaj\u0101m funkcij\u0101m<\/h2>\n

      P\u0113t\u012bjumi par Selanku liecina par iesp\u0113jam\u0101m priek\u0161roc\u012bb\u0101m \u0161\u0101d\u0101s jom\u0101s:<\/p>\n

        \n
      • operat\u012bv\u0101s atmi\u0146as,<\/li>\n
      • koncentr\u0101cijas,<\/li>\n
      • stresa notur\u012bba,<\/li>\n
      • kognit\u012bv\u0101s funkcijas psiholo\u0123iska stresa situ\u0101cij\u0101s.<\/li>\n<\/ul>\n

        Afobazols var ar\u012b izr\u0101d\u012bt da\u017eus kognit\u012bvos ieguvumus, ta\u010du tie nav t\u0101 galven\u0101 p\u0113t\u012bjumu joma.<\/p>\n

        Dro\u0161\u012bbas profils<\/h2>\n

        Pieejamie p\u0113t\u012bjumi liecina, ka abi prepar\u0101ti parasti tiek labi panesami.<\/p>\n

        Selank:<\/strong><\/p>\n

          \n
        • sporadiska deguna kairin\u0101\u0161ana,<\/li>\n
        • spor\u0101diskas galvass\u0101pes,<\/li>\n
        • p\u0101rejo\u0161s nogurums.<\/li>\n<\/ul>\n

          Afobazols:<\/strong><\/p>\n

            \n
          • vieglas ku\u0146\u0123a probl\u0113mas,<\/li>\n
          • slik\u010dinas,<\/li>\n
          • retas aler\u0123isk\u0101s reakcijas.<\/li>\n<\/ul>\n

            Public\u0113tajos p\u0113t\u012bjumos netika konstat\u0113ts b\u016btisks atkar\u012bbas risks vai abstinences simptomi nevienam no \u0161iem prepar\u0101tiem.<\/p>\n

            Atruna<\/h2>\n

            Saturs ir paredz\u0113ts tikai izgl\u012btojo\u0161iem un informat\u012bviem nol\u016bkiem, un to nevajadz\u0113tu interpret\u0113t k\u0101 medic\u012bnisku padomu, diagnozi vai terapeitisku ieteikumu. Selank un Afobazole nav apstiprin\u0101jusi Amerikas Savienoto Valstu P\u0101rtikas un z\u0101\u013cu p\u0101rvalde (FDA) vai Eiropas Z\u0101\u013cu a\u0123ent\u016bra (EMA) trauksmes trauc\u0113jumu vai citu slim\u012bbu \u0101rst\u0113\u0161anai. Liel\u0101k\u0101 da\u013ca pieejamo datu n\u0101k no p\u0113t\u012bjumiem, kas veikti Krievij\u0101 un Austrumeirop\u0101. Lai lab\u0101k noteiktu to efektivit\u0101ti, dro\u0161umu un ilgtermi\u0146a ietekmi, ir nepiecie\u0161ami papildu, labi izstr\u0101d\u0101ti kl\u012bniskie p\u0113t\u012bjumi.<\/p>","protected":false},"excerpt":{"rendered":"

            Selank un Afobazole ir divi Krievij\u0101 izstr\u0101d\u0101ti prepar\u0101ti, kuru m\u0113r\u0137is ir mazin\u0101t trauksmi un uzlabot notur\u012bbu pret stresu. Lai gan abiem piem\u012bt prettrauksmes iedarb\u012bba, neizraisot\u2026<\/p>","protected":false},"author":7908,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[192],"tags":[],"class_list":["post-51228","post","type-post","status-publish","format-standard","hentry","category-kategoria-selank","beh-no-thumb"],"_links":{"self":[{"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/posts\/51228","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/users\/7908"}],"replies":[{"embeddable":true,"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/comments?post=51228"}],"version-history":[{"count":0,"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/posts\/51228\/revisions"}],"wp:attachment":[{"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/media?parent=51228"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/categories?post=51228"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/tags?post=51228"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}